Flemington-based pharmaceutical company specializing in drug-free consumer healthcare products, announced today that the company’s Strategic Alliance with Aurena Laboratories, AB of Karlstad, Sweden, for the joint development of sparkling saline and a related line of products, has made significant progress.
Flemington, NJ (PRWEB) May 10, 2016
Stan Lech, President of Clover Hill Healthcare, Inc., a Flemington-based pharmaceutical company specializing in drug-free consumer healthcare products, announced today that the company’s Strategic Alliance with Aurena Laboratories, AB of Karlstad, Sweden, for the joint development of sparkling saline and a related line of products, has made significant progress. Magnus Hedman, Business Development Director of Aurena, stated that his company is one of the largest and highest quality manufacturers of saline nasal spray with more than twenty different brand customers. Clover Hill’s new sparkling saline technology platform will be offered to Aurena customers in July as premium, consumer-preferred and expert-recommended products that will expand and grow the Respiratory Health market across Europe, Western Asia and Africa for Aurena. Lars Hedman, Managing Director of Aurena announced that the company has completed construction of additional manufacturing facilities that will more than double current production capacity for Aurena. The Clover Hill sparkling saline production line will be fully operative in June at the Aurena facility and new carbonator equipment has been installed and tested.
Ken Glynn, Chairman of Clover Hill and inventor of the sparkling saline technology platform, stated that all current manufacturing will be done in Sweden at Aurena and that Clover Hill will spearhead distribution in the USA, Canada, Mexico, China, Australia, New Zealand and Southeast Asia. Ken stated that "this Alliance effectively leverages the best of both organizations, which include commercial creativity, deep consumer and medical insights, excellence in science and intellectual property know-how, and high quality, global distribution capabilities.” Ken described the sparkling saline product as one with a refreshing, unique and therapeutic cleansing experience compared to normal saline nasal spray. Recent focus group and other studies showed that the Clover Hill sparkling products appeal to and are preferred by consumers that frequently use nasal saline and other nasal congestion relief products. Ken said, "the US nasal health market is a multi-billion dollar segment just waiting to be disrupted by drug-free products that deliver unique sensory benefits and superior efficacy". Stan Lech, Clover Hill president, stated that their first patent issued earlier this year and that there are numerous other U. S. and foreign pending patent applications on Ken’s sparkling saline products and methods. The nasal sparkling saline products will launch worldwide later in 2016 under well know brand names and including Clover Hill’s own brand “Clear Ahead”, http://www.clear-ahead.com. Both Clover Hill and Aurena expressed excitement in advancing further clinical studies that would establish sparkling saline as the superior and safest product for the prevention of nasal allergy symptoms thus giving the current respiratory product leaders who market intranasal steroids, such as Flonase and Nasacort, a run for their money.
Contact: Ken Glynn, USA 908.507.3433
For the original version on PRWeb visit: http://www.prweb.com/releases/CLEARAHEAD/SPARKLINGSALINE/prweb13400223.htm